Injectable pill鈥檚 link with HIV
Print Edition
WOMEN who use a specific type of injectable birth control have a slightly higher risk of HIV infection than those who take the pill, said a study yesterday.
While the authors noted the link was “statistically significant,” they warned it was not enough on its own to justify a complete withdrawal of the drug commonly known by its brand name, Depo-Provera, used by millions of women.
The health risks of pulling the medicine from shelves may far outweigh the potential preventable HIV infections, the authors argued in a paper published in the prestigious medical journal, The Lancet Infectious Diseases.
A meta-analysis of 12 studies involving nearly 40,000 women in sub-Saharan Africa showed that use of depot medroxyprogesterone acetate (DMPA) “increases a woman’s chance of becoming infected with HIV by 40 percent compared with women using other contraceptive methods or no method,” said a statement.
“Although statistically significant, this represents only a moderate increase in relative risk,” it added.
The increase in risk was somewhat lower among women “in the general population” than for those already at higher HIV risk, like sex workers.
The analysis showed no increased risk for users of other contraceptive drugs. All the studies had factored in condom use.
“The moderate elevation in risk observed in our study is not enough to justify a complete withdrawal of DMPA for women in the general population,” said study co-author Lauren Ralph of the University of California at Berkeley.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
